Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/12435
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jerums, George | en |
dc.contributor.author | Allen, Terri J | en |
dc.contributor.author | Cooper, Mark E | en |
dc.date.accessioned | 2015-05-16T02:08:02Z | |
dc.date.available | 2015-05-16T02:08:02Z | |
dc.date.issued | 1989-12-01 | en |
dc.identifier.citation | Diabetic Medicine : A Journal of the British Diabetic Association; 6(9): 772-9 | en |
dc.identifier.govdoc | 2533035 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | http://ahro.austin.org.au/austinjspui/handle/1/12435 | en |
dc.description.abstract | Two indices of the selectivity of proteinuria, the immunoglobulin G (IgG)/albumin and the IgG/transferrin clearance ratios, were studied cross-sectionally and serially over 7 years in a cohort of 52 Type 1 and 60 Type 2 diabetic patients without established diabetic nephropathy. In Type 1 and Type 2 diabetic patients with albuminuria less than 30 micrograms min-1, both protein clearance ratios were significantly higher than in 27 control subjects. As albuminuria increased, there was a decrease in both protein clearance ratios. However, at albumin clearances above 90 nl s-1, equivalent to albumin excretion rates of greater than 250 micrograms min-1, a positive correlation was found in Type 2 diabetic patients between protein clearance ratios and albuminuria. In individual Type 1 and Type 2 diabetic patients with progressively increasing proteinuria, serial measurements of selectivity showed a decline in both protein clearance ratios with the onset of microalbuminuria. Episodes of transient microalbuminuria were also associated with a fall in the IgG/albumin clearance ratio. The results suggest that the selectivity of proteinuria undergoes a triphasic change with the development of diabetic nephropathy. In the first phase, proteinuria is non-selective with IgG clearance equal to or exceeding transferrin or albumin clearance. As microalbuminuria develops, there is a progressive increase in selectivity reflecting the preferential excretion of transferrin and albumin compared with IgG. In later stages of nephropathy, as shown in Type 2 diabetic patients with macroalbuminuria, there is a return to non-selective proteinuria. | en |
dc.language.iso | en | en |
dc.subject.other | Albuminuria | en |
dc.subject.other | Blood Glucose.analysis | en |
dc.subject.other | Blood Pressure | en |
dc.subject.other | Cohort Studies | en |
dc.subject.other | Diabetes Mellitus, Type 1.physiopathology.urine | en |
dc.subject.other | Diabetes Mellitus, Type 2.physiopathology.urine | en |
dc.subject.other | Diabetic Nephropathies.urine | en |
dc.subject.other | Female | en |
dc.subject.other | Follow-Up Studies | en |
dc.subject.other | Hemoglobin A, Glycosylated.analysis | en |
dc.subject.other | Humans | en |
dc.subject.other | Immunoglobulin G.metabolism | en |
dc.subject.other | Kidney Function Tests | en |
dc.subject.other | Male | en |
dc.subject.other | Metabolic Clearance Rate | en |
dc.subject.other | Proteinuria | en |
dc.subject.other | Transferrin.metabolism | en |
dc.title | Triphasic changes in selectivity with increasing proteinuria in type 1 and type 2 diabetes. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Diabetic medicine : a journal of the British Diabetic Association | en |
dc.identifier.affiliation | Department of Medicine, Austin Hospital, Heidelberg, Australia | en |
dc.description.pages | 772-9 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/2533035 | en |
dc.type.austin | Journal Article | en |
item.openairetype | Journal Article | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Endocrinology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.